Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study
Purpose This study examines sick leave (SL) and factors associated with full-time SL 1 year after allogeneic haematopoietic stem cell transplantation (allo-HSCT) in patients of working age from 2009 to 2016 ( n = 122). Methods Questionnaire data were collected on admission to the allo-HSCT unit, at...
Gespeichert in:
| Veröffentlicht in: | Journal of cancer survivorship 2021-12, Vol.15 (6), p.933-941 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 941 |
|---|---|
| container_issue | 6 |
| container_start_page | 933 |
| container_title | Journal of cancer survivorship |
| container_volume | 15 |
| creator | Eriksson, Linda Wennman-Larsen, Agneta Bergkvist, Karin Ljungman, Per Winterling, Jeanette |
| description | Purpose
This study examines sick leave (SL) and factors associated with full-time SL 1 year after allogeneic haematopoietic stem cell transplantation (allo-HSCT) in patients of working age from 2009 to 2016 (
n
= 122).
Methods
Questionnaire data were collected on admission to the allo-HSCT unit, at 7 months and 1 year after allo-HSCT. Associations between factors and SL were analysed using logistic regression analyses.
Results
One year after allo-HSCT, 76% of participants were on SL, with 36% on full-time SL. In univariable analyses, chronic graft-versus-host-disease (cGvHD) (OR 3.07; 95% CI 1.34–7.07;
p
= 0.01), having symptoms of depression at 7 months (OR 4.81; 95% CI 1.69–13.69;
p
= 0.00) and low levels of vocational satisfaction at 7 months after treatment (OR 3.27; 95% CI 1.27–8.41;
p
= 0.01) were associated with full-time SL 1 year after allo-HSCT. cGvHD (OR 3.43; 95% CI 1.35–8.73;
p
= 0.01) and having symptoms of depression at 7 months after allo-HSCT (OR 3.37; 95% CI 1.2–11.58;
p
= 0.02) remained significant in multivariable analysis.
Conclusion
The majority of allo-HSCT survivors were on SL 1 year after treatment, and cGvHD, low vocational satisfaction and depressive symptoms were associated with full-time SL 1 year after allo-HSCT.
Implications for Cancer Survivors
Healthcare professionals need to be observant of and manage the consequences of cGvHD and patients’ symptoms of depression in order to support them appropriately in their return-to-work process. |
| doi_str_mv | 10.1007/s11764-020-00986-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_465307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2582277279</sourcerecordid><originalsourceid>FETCH-LOGICAL-c548t-50701e39e96bcd56843ad49c14d7275353bc8fc3b06f811ff68f22bca6de9c553</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEohd4ARbIEptKVcCX2I43SFW5VarEBthajnMy4zaJg-20mh0Sr8AT8iQ4zDBQJFj52Ofz7-Nff1E8Ifg5wVi-iIRIUZWY4hJjVYuS3ysOiWK0pFTI-_uaq4PiKMYrjDlVhD4sDhiriCQ1OSy-XgyTD8mMCXXGJh8iMjF660yCFt26tEbR2WvUg7kBZLoEAZm-9ysYwVm0NjCY5CfvIOVtTDAgC32PUjBjnPqsa5Lz4_cv3wwi5QZMQFPwcQKbXBaMaW43j4oHnekjPN6tx8XHN68_nL8rL9-_vTg_uywtr-pUciwxAaZAica2XNQVM22lLKlaSSVnnDW27ixrsOhqQrpO1B2ljTWiBWU5Z8dFudWNtzDNjZ6CG0zYaG-c3h1d5wp0JTjDMvOn_-RfuU9n2oeVjuu1Zkos6i-3dEYHaC2M2YP-zqW7ndGt9crfaCkVVmwRONkJBP95hpj04OJiphnBz1HTSgouKK3rjD77C73ycxizeZrymlKZDVGZolvKZsdjgG4_DMF6SZDeJkjnBOmfCdLLFE___Mb-yq_IZIDtXMmtcQXh99v_kf0B86TXIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2582277279</pqid></control><display><type>article</type><title>Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study</title><source>MEDLINE</source><source>SWEPUB Freely available online</source><source>SpringerLink Journals - AutoHoldings</source><creator>Eriksson, Linda ; Wennman-Larsen, Agneta ; Bergkvist, Karin ; Ljungman, Per ; Winterling, Jeanette</creator><creatorcontrib>Eriksson, Linda ; Wennman-Larsen, Agneta ; Bergkvist, Karin ; Ljungman, Per ; Winterling, Jeanette</creatorcontrib><description>Purpose
This study examines sick leave (SL) and factors associated with full-time SL 1 year after allogeneic haematopoietic stem cell transplantation (allo-HSCT) in patients of working age from 2009 to 2016 (
n
= 122).
Methods
Questionnaire data were collected on admission to the allo-HSCT unit, at 7 months and 1 year after allo-HSCT. Associations between factors and SL were analysed using logistic regression analyses.
Results
One year after allo-HSCT, 76% of participants were on SL, with 36% on full-time SL. In univariable analyses, chronic graft-versus-host-disease (cGvHD) (OR 3.07; 95% CI 1.34–7.07;
p
= 0.01), having symptoms of depression at 7 months (OR 4.81; 95% CI 1.69–13.69;
p
= 0.00) and low levels of vocational satisfaction at 7 months after treatment (OR 3.27; 95% CI 1.27–8.41;
p
= 0.01) were associated with full-time SL 1 year after allo-HSCT. cGvHD (OR 3.43; 95% CI 1.35–8.73;
p
= 0.01) and having symptoms of depression at 7 months after allo-HSCT (OR 3.37; 95% CI 1.2–11.58;
p
= 0.02) remained significant in multivariable analysis.
Conclusion
The majority of allo-HSCT survivors were on SL 1 year after treatment, and cGvHD, low vocational satisfaction and depressive symptoms were associated with full-time SL 1 year after allo-HSCT.
Implications for Cancer Survivors
Healthcare professionals need to be observant of and manage the consequences of cGvHD and patients’ symptoms of depression in order to support them appropriately in their return-to-work process.</description><identifier>ISSN: 1932-2259</identifier><identifier>ISSN: 1932-2267</identifier><identifier>EISSN: 1932-2267</identifier><identifier>DOI: 10.1007/s11764-020-00986-5</identifier><identifier>PMID: 33417181</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Allogeneic haematopoietic stem cell transplantation ; Employee benefits ; Graft vs Host Disease ; Health Informatics ; Health Promotion and Disease Prevention ; Health services ; Hematopoietic Stem Cell Transplantation ; Hematopoietic stem cells ; Humans ; Medicine ; Medicine & Public Health ; Mental depression ; Oncology ; Patients ; Primary Care Medicine ; Prospective Studies ; Public Health ; Quality of Life Research ; Retrospective Studies ; Return to work ; Sick Leave ; Sickness absence ; Signs and symptoms ; Stem cell transplantation ; Stem cells ; Transplantation</subject><ispartof>Journal of cancer survivorship, 2021-12, Vol.15 (6), p.933-941</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c548t-50701e39e96bcd56843ad49c14d7275353bc8fc3b06f811ff68f22bca6de9c553</citedby><cites>FETCH-LOGICAL-c548t-50701e39e96bcd56843ad49c14d7275353bc8fc3b06f811ff68f22bca6de9c553</cites><orcidid>0000-0003-0661-4890</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11764-020-00986-5$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11764-020-00986-5$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,552,780,784,885,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33417181$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:shh:diva-3965$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:145552161$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Eriksson, Linda</creatorcontrib><creatorcontrib>Wennman-Larsen, Agneta</creatorcontrib><creatorcontrib>Bergkvist, Karin</creatorcontrib><creatorcontrib>Ljungman, Per</creatorcontrib><creatorcontrib>Winterling, Jeanette</creatorcontrib><title>Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study</title><title>Journal of cancer survivorship</title><addtitle>J Cancer Surviv</addtitle><addtitle>J Cancer Surviv</addtitle><description>Purpose
This study examines sick leave (SL) and factors associated with full-time SL 1 year after allogeneic haematopoietic stem cell transplantation (allo-HSCT) in patients of working age from 2009 to 2016 (
n
= 122).
Methods
Questionnaire data were collected on admission to the allo-HSCT unit, at 7 months and 1 year after allo-HSCT. Associations between factors and SL were analysed using logistic regression analyses.
Results
One year after allo-HSCT, 76% of participants were on SL, with 36% on full-time SL. In univariable analyses, chronic graft-versus-host-disease (cGvHD) (OR 3.07; 95% CI 1.34–7.07;
p
= 0.01), having symptoms of depression at 7 months (OR 4.81; 95% CI 1.69–13.69;
p
= 0.00) and low levels of vocational satisfaction at 7 months after treatment (OR 3.27; 95% CI 1.27–8.41;
p
= 0.01) were associated with full-time SL 1 year after allo-HSCT. cGvHD (OR 3.43; 95% CI 1.35–8.73;
p
= 0.01) and having symptoms of depression at 7 months after allo-HSCT (OR 3.37; 95% CI 1.2–11.58;
p
= 0.02) remained significant in multivariable analysis.
Conclusion
The majority of allo-HSCT survivors were on SL 1 year after treatment, and cGvHD, low vocational satisfaction and depressive symptoms were associated with full-time SL 1 year after allo-HSCT.
Implications for Cancer Survivors
Healthcare professionals need to be observant of and manage the consequences of cGvHD and patients’ symptoms of depression in order to support them appropriately in their return-to-work process.</description><subject>Allogeneic haematopoietic stem cell transplantation</subject><subject>Employee benefits</subject><subject>Graft vs Host Disease</subject><subject>Health Informatics</subject><subject>Health Promotion and Disease Prevention</subject><subject>Health services</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Hematopoietic stem cells</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mental depression</subject><subject>Oncology</subject><subject>Patients</subject><subject>Primary Care Medicine</subject><subject>Prospective Studies</subject><subject>Public Health</subject><subject>Quality of Life Research</subject><subject>Retrospective Studies</subject><subject>Return to work</subject><subject>Sick Leave</subject><subject>Sickness absence</subject><subject>Signs and symptoms</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Transplantation</subject><issn>1932-2259</issn><issn>1932-2267</issn><issn>1932-2267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>D8T</sourceid><recordid>eNp9kstu1DAUhiMEohd4ARbIEptKVcCX2I43SFW5VarEBthajnMy4zaJg-20mh0Sr8AT8iQ4zDBQJFj52Ofz7-Nff1E8Ifg5wVi-iIRIUZWY4hJjVYuS3ysOiWK0pFTI-_uaq4PiKMYrjDlVhD4sDhiriCQ1OSy-XgyTD8mMCXXGJh8iMjF660yCFt26tEbR2WvUg7kBZLoEAZm-9ysYwVm0NjCY5CfvIOVtTDAgC32PUjBjnPqsa5Lz4_cv3wwi5QZMQFPwcQKbXBaMaW43j4oHnekjPN6tx8XHN68_nL8rL9-_vTg_uywtr-pUciwxAaZAica2XNQVM22lLKlaSSVnnDW27ixrsOhqQrpO1B2ljTWiBWU5Z8dFudWNtzDNjZ6CG0zYaG-c3h1d5wp0JTjDMvOn_-RfuU9n2oeVjuu1Zkos6i-3dEYHaC2M2YP-zqW7ndGt9crfaCkVVmwRONkJBP95hpj04OJiphnBz1HTSgouKK3rjD77C73ycxizeZrymlKZDVGZolvKZsdjgG4_DMF6SZDeJkjnBOmfCdLLFE___Mb-yq_IZIDtXMmtcQXh99v_kf0B86TXIA</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Eriksson, Linda</creator><creator>Wennman-Larsen, Agneta</creator><creator>Bergkvist, Karin</creator><creator>Ljungman, Per</creator><creator>Winterling, Jeanette</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>ACDKN</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF4</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0003-0661-4890</orcidid></search><sort><creationdate>20211201</creationdate><title>Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study</title><author>Eriksson, Linda ; Wennman-Larsen, Agneta ; Bergkvist, Karin ; Ljungman, Per ; Winterling, Jeanette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c548t-50701e39e96bcd56843ad49c14d7275353bc8fc3b06f811ff68f22bca6de9c553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Allogeneic haematopoietic stem cell transplantation</topic><topic>Employee benefits</topic><topic>Graft vs Host Disease</topic><topic>Health Informatics</topic><topic>Health Promotion and Disease Prevention</topic><topic>Health services</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Hematopoietic stem cells</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mental depression</topic><topic>Oncology</topic><topic>Patients</topic><topic>Primary Care Medicine</topic><topic>Prospective Studies</topic><topic>Public Health</topic><topic>Quality of Life Research</topic><topic>Retrospective Studies</topic><topic>Return to work</topic><topic>Sick Leave</topic><topic>Sickness absence</topic><topic>Signs and symptoms</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eriksson, Linda</creatorcontrib><creatorcontrib>Wennman-Larsen, Agneta</creatorcontrib><creatorcontrib>Bergkvist, Karin</creatorcontrib><creatorcontrib>Ljungman, Per</creatorcontrib><creatorcontrib>Winterling, Jeanette</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Sophiahemmet Högskola full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Sophiahemmet Högskola</collection><collection>SwePub Articles full text</collection><jtitle>Journal of cancer survivorship</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eriksson, Linda</au><au>Wennman-Larsen, Agneta</au><au>Bergkvist, Karin</au><au>Ljungman, Per</au><au>Winterling, Jeanette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study</atitle><jtitle>Journal of cancer survivorship</jtitle><stitle>J Cancer Surviv</stitle><addtitle>J Cancer Surviv</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>15</volume><issue>6</issue><spage>933</spage><epage>941</epage><pages>933-941</pages><issn>1932-2259</issn><issn>1932-2267</issn><eissn>1932-2267</eissn><abstract>Purpose
This study examines sick leave (SL) and factors associated with full-time SL 1 year after allogeneic haematopoietic stem cell transplantation (allo-HSCT) in patients of working age from 2009 to 2016 (
n
= 122).
Methods
Questionnaire data were collected on admission to the allo-HSCT unit, at 7 months and 1 year after allo-HSCT. Associations between factors and SL were analysed using logistic regression analyses.
Results
One year after allo-HSCT, 76% of participants were on SL, with 36% on full-time SL. In univariable analyses, chronic graft-versus-host-disease (cGvHD) (OR 3.07; 95% CI 1.34–7.07;
p
= 0.01), having symptoms of depression at 7 months (OR 4.81; 95% CI 1.69–13.69;
p
= 0.00) and low levels of vocational satisfaction at 7 months after treatment (OR 3.27; 95% CI 1.27–8.41;
p
= 0.01) were associated with full-time SL 1 year after allo-HSCT. cGvHD (OR 3.43; 95% CI 1.35–8.73;
p
= 0.01) and having symptoms of depression at 7 months after allo-HSCT (OR 3.37; 95% CI 1.2–11.58;
p
= 0.02) remained significant in multivariable analysis.
Conclusion
The majority of allo-HSCT survivors were on SL 1 year after treatment, and cGvHD, low vocational satisfaction and depressive symptoms were associated with full-time SL 1 year after allo-HSCT.
Implications for Cancer Survivors
Healthcare professionals need to be observant of and manage the consequences of cGvHD and patients’ symptoms of depression in order to support them appropriately in their return-to-work process.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33417181</pmid><doi>10.1007/s11764-020-00986-5</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0661-4890</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-2259 |
| ispartof | Journal of cancer survivorship, 2021-12, Vol.15 (6), p.933-941 |
| issn | 1932-2259 1932-2267 1932-2267 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_465307 |
| source | MEDLINE; SWEPUB Freely available online; SpringerLink Journals - AutoHoldings |
| subjects | Allogeneic haematopoietic stem cell transplantation Employee benefits Graft vs Host Disease Health Informatics Health Promotion and Disease Prevention Health services Hematopoietic Stem Cell Transplantation Hematopoietic stem cells Humans Medicine Medicine & Public Health Mental depression Oncology Patients Primary Care Medicine Prospective Studies Public Health Quality of Life Research Retrospective Studies Return to work Sick Leave Sickness absence Signs and symptoms Stem cell transplantation Stem cells Transplantation |
| title | Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T07%3A28%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Important%20factors%20associated%20with%20sick%20leave%20after%20allogeneic%20haematopoietic%20stem%20cell%20transplantation%E2%80%94a%201-year%20prospective%20study&rft.jtitle=Journal%20of%20cancer%20survivorship&rft.au=Eriksson,%20Linda&rft.date=2021-12-01&rft.volume=15&rft.issue=6&rft.spage=933&rft.epage=941&rft.pages=933-941&rft.issn=1932-2259&rft.eissn=1932-2267&rft_id=info:doi/10.1007/s11764-020-00986-5&rft_dat=%3Cproquest_swepu%3E2582277279%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2582277279&rft_id=info:pmid/33417181&rfr_iscdi=true |